BLFS
BioLife Solutions, Inc. NASDAQ Listed Nov 22, 1989$26.04
+1.80%
vs $25.58
Mkt Cap $1.3B
52w Low $18.15
74.2% of range
52w High $28.79
50d MA $23.28
200d MA $23.98
P/E (TTM)
-104.2x
EV/EBITDA
—
P/B
3.3x
Debt/Equity
0.1x
ROE
-1.2%
P/FCF
119.1x
RSI (14)
56.20
ATR (14)
$1.41
Beta
2.00
50d MA
$23.28
200d MA
$23.98
Avg Volume
733.7K
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. It markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington.
3303 Monte Villa Parkway · Bothell, WA 98021 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | AMC | 0.01 | 0.04 | +300.0% | 23.12 | -5.7% | -4.7% | -1.4% | -2.3% | -0.3% | -0.5% | — |
| Feb 26, 2026 | AMC | -0.02 | 0.04 | +300.0% | 22.48 | +4.5% | +7.7% | -6.9% | -10.4% | +2.5% | -2.7% | — |
| Nov 6, 2025 | AMC | 0.00 | 0.04 | +1900.0% | 27.02 | -0.6% | -4.0% | +1.4% | -1.0% | -0.5% | -3.0% | — |
| Aug 7, 2025 | AMC | -0.03 | -0.33 | -888.4% | 20.64 | +6.4% | +9.9% | -1.4% | +7.6% | +6.7% | -1.4% | — |
| May 8, 2025 | AMC | -0.05 | 0.04 | +182.4% | 22.36 | -4.2% | +4.2% | +2.6% | -3.3% | -4.5% | -0.3% | — |
| Mar 3, 2025 | AMC | -0.06 | -0.01 | +83.3% | 24.51 | -2.0% | +1.3% | +5.7% | +2.1% | -3.6% | -3.8% | — |
| Nov 12, 2024 | AMC | -0.08 | -0.02 | +74.4% | 26.50 | -0.8% | -9.0% | -10.2% | -2.9% | -2.6% | +9.6% | — |
| Aug 8, 2024 | AMC | -0.14 | -0.06 | +56.6% | 22.74 | +7.7% | +11.0% | +2.2% | +2.8% | -2.3% | -0.5% | — |
| May 9, 2024 | AMC | -0.28 | -0.23 | +17.9% | 18.01 | -0.6% | +8.5% | +5.7% | +8.6% | +2.5% | -4.4% | — |
| Feb 29, 2024 | AMC | -0.34 | -0.30 | +11.8% | 16.90 | -13.9% | +6.3% | +1.0% | -6.2% | +2.9% | -1.5% | — |
| Nov 9, 2023 | AMC | -0.38 | -0.67 | -78.7% | 11.39 | -4.0% | -3.9% | -1.6% | +11.0% | +3.1% | -3.1% | — |
| Aug 8, 2023 | AMC | -0.20 | -0.23 | -15.0% | 18.39 | -15.7% | -28.7% | -5.3% | -2.3% | +3.8% | -2.6% | — |
| May 10, 2023 | AMC | -0.21 | -0.32 | -52.4% | 18.61 | -2.7% | -1.9% | +3.0% | +3.5% | +4.0% | +8.3% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 29 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $24.90 | $24.79 | -0.4% | +0.9% | -1.8% | -1.9% | -1.2% | +5.9% |
| Nov 24 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $26.53 | $26.54 | +0.0% | -0.7% | +2.4% | -1.1% | -0.7% | -4.1% |
| Aug 8 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $20.64 | $21.97 | +6.4% | +9.9% | -1.4% | +7.6% | +6.7% | -1.4% |
| May 13 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $23.89 | $23.93 | +0.2% | -3.3% | -4.5% | -0.3% | +7.3% | -2.8% |
| Mar 6 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $26.25 | $26.15 | -0.4% | +2.1% | -3.6% | -3.8% | +7.1% | -1.3% |
| Jan 8 | Northland Capital Markets | Maintains | Outperform → Outperform | — | $27.11 | $27.50 | +1.4% | +2.1% | -3.9% | +1.4% | -2.6% | +1.7% |
| Dec 19 | Benchmark | Maintains | Buy → Buy | — | $24.98 | $25.44 | +1.8% | +4.5% | +4.9% | -3.7% | +0.5% | +2.0% |
| Dec 13 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $26.72 | $26.77 | +0.2% | -0.1% | +2.5% | -1.8% | -7.0% | +4.5% |
| Nov 18 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $21.02 | $20.30 | -3.4% | -2.6% | +9.6% | +11.5% | +1.5% | +2.4% |
| Nov 13 | TD Cowen | Maintains | Buy → Buy | — | $26.50 | $26.30 | -0.8% | -9.0% | -10.2% | -2.9% | -2.6% | +9.6% |
| Nov 13 | Craig-Hallum | Maintains | Buy → Buy | — | $26.50 | $26.30 | -0.8% | -9.0% | -10.2% | -2.9% | -2.6% | +9.6% |
| Aug 12 | Craig-Hallum | Maintains | Buy → Buy | — | $25.25 | $25.31 | +0.2% | +2.2% | +2.8% | -2.3% | -0.5% | +0.3% |
| Aug 9 | Northland Capital Markets | Maintains | Outperform → Outperform | — | $22.74 | $24.48 | +7.7% | +11.0% | +2.2% | +2.8% | -2.3% | -0.5% |
| Jul 17 | TD Cowen | Maintains | Buy → Buy | — | $22.77 | $22.57 | -0.9% | -1.1% | -4.7% | -2.0% | +3.1% | +5.0% |
| May 13 | Benchmark | Upgrade | Hold → Buy | — | $19.54 | $20.66 | +5.7% | +5.7% | +8.6% | +2.5% | -4.4% | -0.0% |
| Aug 10 | Craig-Hallum | Maintains | Buy → Buy | — | $13.11 | $13.03 | -0.6% | -5.3% | -2.3% | +3.8% | -2.6% | -4.9% |
| Aug 9 | Lake Street | Maintains | Buy → Buy | — | $18.39 | $15.51 | -15.7% | -28.7% | -5.3% | -2.3% | +3.8% | -2.6% |
| Aug 9 | TD Cowen | Maintains | Outperform → Outperform | — | $18.39 | $15.51 | -15.7% | -28.7% | -5.3% | -2.3% | +3.8% | -2.6% |
| Jul 17 | Stephens & Co. | Maintains | Overweight → Overweight | — | $19.62 | $19.83 | +1.1% | +2.8% | +0.9% | -0.6% | -1.0% | +0.2% |
| Mar 17 | Stephens & Co. | Maintains | Overweight → Overweight | — | $19.98 | $18.91 | -5.4% | +7.7% | -3.5% | +6.2% | -4.9% | +2.7% |
| Mar 6 | Oppenheimer | Maintains | Outperform → Outperform | — | $23.93 | $23.98 | +0.2% | -4.9% | -0.3% | -0.3% | -0.6% | -13.3% |
| May 10 | Stephens & Co. | Maintains | Overweight → Overweight | — | $10.90 | $11.51 | +5.6% | +7.8% | -10.3% | +5.9% | +11.3% | +2.5% |
| May 10 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $10.90 | $11.51 | +5.6% | +7.8% | -10.3% | +5.9% | +11.3% | +2.5% |
| Apr 25 | Oppenheimer | Upgrade | Perform → Outperform | — | $12.59 | $13.35 | +6.0% | +9.5% | -4.4% | -3.5% | +2.2% | -2.6% |
| Aug 13 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $48.06 | $49.98 | +4.0% | -5.7% | +0.7% | -2.9% | -0.2% | +4.4% |
| May 14 | Benchmark | Downgrade | Buy → Hold | — | $29.53 | $28.76 | -2.6% | +0.7% | +2.8% | +4.2% | -1.2% | +4.7% |
| Mar 23 | KeyBanc | Maintains | Overweight → Overweight | — | $38.57 | $46.50 | +20.6% | +8.8% | -7.2% | -3.2% | -5.3% | -1.0% |
| Mar 23 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $38.57 | $46.50 | +20.6% | +8.8% | -7.2% | -3.2% | -5.3% | -1.0% |
| Mar 23 | Benchmark | Upgrade | Hold → Buy | — | $38.57 | $46.50 | +20.6% | +8.8% | -7.2% | -3.2% | -5.3% | -1.0% |
| Mar 22 | KeyBanc | Maintains | Overweight → Overweight | — | $38.76 | $39.09 | +0.9% | -0.5% | +8.8% | -7.2% | -3.2% | -5.3% |
| Nov 10 | KeyBanc | Maintains | Overweight → Overweight | — | $32.10 | $32.95 | +2.6% | +0.5% | +2.7% | -3.4% | +0.6% | -3.2% |
| Sep 22 | Oppenheimer | Downgrade | Outperform → Perform | — | $26.40 | $25.66 | -2.8% | +2.2% | +0.7% | -4.0% | +0.6% | +3.0% |
| Sep 18 | TD Cowen | Maintains | Outperform → Outperform | — | $25.43 | $26.25 | +3.2% | +7.0% | -3.0% | +2.2% | +0.7% | -4.0% |
| Aug 11 | Benchmark | Downgrade | Buy → Hold | — | $22.57 | $21.24 | -5.9% | -12.2% | -7.5% | +2.9% | -1.9% | +4.6% |
| May 4 | B. Riley Securities | Maintains | Buy → Buy | — | $10.54 | $10.58 | +0.4% | +8.8% | +8.3% | +0.8% | +4.6% | +3.9% |
| May 4 | B. Riley FBR | Maintains | Buy → Buy | — | $10.54 | $10.58 | +0.4% | +8.8% | +8.3% | +0.8% | +4.6% | +3.9% |
| Mar 23 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $9.12 | $9.05 | -0.8% | -4.2% | +5.4% | -0.3% | +9.8% | -6.8% |
| Mar 12 | B. Riley Securities | Maintains | Buy → Buy | — | $12.25 | $11.00 | -10.2% | -29.5% | +4.5% | -7.4% | +14.4% | +3.7% |
| Mar 12 | B. Riley FBR | Maintains | Buy → Buy | — | $12.25 | $11.00 | -10.2% | -29.5% | +4.5% | -7.4% | +14.4% | +3.7% |
| Feb 24 | Lake Street | Maintains | Buy → Buy | — | $15.63 | $15.35 | -1.8% | +0.9% | -3.6% | -2.6% | -1.5% | -3.0% |
| Feb 19 | Benchmark | Maintains | Buy → Buy | — | $15.54 | $16.11 | +3.7% | +5.0% | -0.7% | -3.6% | +0.9% | -3.6% |
| Feb 6 | B. Riley | Maintains | Buy → Buy | — | $14.30 | $14.88 | +4.1% | -3.0% | -0.4% | +0.3% | +0.9% | +2.0% |
| Dec 16 | H.C. Wainwright | Maintains | Buy → Buy | — | $15.67 | $16.00 | +2.1% | -0.6% | +1.5% | +3.8% | -1.6% | -3.9% |
| Nov 21 | Oppenheimer | Maintains | Outperform → Outperform | — | $15.55 | $15.83 | +1.8% | +6.0% | +2.0% | -1.0% | -2.2% | +0.9% |
| Sep 4 | Northland Capital Markets | Maintains | Outperform → Outperform | — | $20.33 | $20.84 | +2.5% | -2.0% | +0.5% | -2.6% | +0.3% | +0.3% |
| Jul 22 | H.C. Wainwright | Maintains | Buy → Buy | — | $17.53 | $17.82 | +1.7% | +7.4% | +2.5% | +3.1% | -2.1% | -1.1% |
| Oct 3 | B. Riley FBR | Maintains | Buy → Buy | — | $16.51 | $16.47 | -0.2% | -15.9% | -3.5% | +1.6% | -4.9% | +2.0% |
| Oct 3 | B. Riley Securities | Maintains | Buy → Buy | — | $16.51 | $16.47 | -0.2% | -15.9% | -3.5% | +1.6% | -4.9% | +2.0% |
| May 11 | Maxim Group | Maintains | Buy → Buy | — | $8.25 | $8.50 | +3.0% | -3.5% | +8.3% | +3.2% | -2.7% | +4.5% |
| Nov 10 | Maxim Group | Maintains | Buy → Buy | — | $5.15 | $5.86 | +13.8% | +14.8% | +5.1% | -1.9% | +1.1% | -7.6% |
No insider trades available.
8-K · 7.01
! Medium
BioLife Solutions, Inc. -- 8-K 7.01: Regulation FD Disclosure
BioLife Solutions is presenting at the Jefferies Global Healthcare Conference to engage investors and analysts, providing updated information about its business strategy and performance.
Jun 3
8-K · 7.01
! Medium
BioLife Solutions Inc. -- 8-K 7.01: Regulation FD Disclosure
BioLife Solutions disclosed an investor presentation, likely outlining its business strategy and financial outlook to capital markets participants.
Mar 2
8-K
BioLife Solutions Inc. -- 8-K Filing
BioLife Solutions achieved 29% revenue growth in 2025 driven by biopreservation media strength and completed a strategic divestiture to refocus as a pure-play cell processing company.
Feb 26
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Invesco Ltd. | 2,348,532 | $45M | Reduced | Mar 2026 |
| 2 | Vanguard Capital Management Llc | 1,917,708 | $37M | New | Mar 2026 |
| 3 | Fmr Llc | 1,470,252 | $28M | Reduced | Mar 2026 |
| 4 | Morgan Stanley | 1,070,080 | $26M | Reduced | Dec 2025 |
| 5 | Bank Of America Corp /de/ | 904,103 | $17M | Added | Mar 2026 |
| 6 | Royal Bank Of Canada | 885,298 | $17M | Added | Mar 2026 |
| 7 | Vanguard Portfolio Management Llc | 865,038 | $17M | New | Mar 2026 |
| 8 | Rockefeller Capital Management L.p. | 741,352 | $14M | Added | Mar 2026 |
| 9 | Geneva Capital Management Llc | 739,803 | $14M | Reduced | Mar 2026 |
| 10 | Mutual Of America Capital Management Llc | 575,463 | $14M | Reduced | Dec 2025 |
| 11 | Voya Investment Management Llc | 496,937 | $12M | — | Dec 2025 |
| 12 | Northern Trust Corp | 442,508 | $8M | Added | Mar 2026 |
| 13 | Raymond James Financial Inc | 444,041 | $8M | Added | Mar 2026 |
| 14 | Next Century Growth Investors Llc | 361,940 | $7M | Added | Mar 2026 |
| 15 | Peregrine Capital Management Llc | 341,847 | $7M | Reduced | Mar 2026 |
| 16 | Russell Investments Group, Ltd. | 268,225 | $5M | Added | Mar 2026 |
| 17 | Ubs Group Ag | 265,978 | $5M | Added | Mar 2026 |
| 18 | Citadel Advisors Llc | 244,172 | $5M | Added | Mar 2026 |
| 19 | Principal Financial Group Inc | 186,613 | $5M | Reduced | Dec 2025 |
| 20 | Jpmorgan Chase & Co | 232,694 | $4M | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$1.27B
Enterprise Value
$1.19B
P/E (TTM)
-104.16x
Forward P/E
176.18x
PEG Ratio
2.20x
P/B
3.34x
P/S
13.17x
P/FCF
119.09x
EV/EBITDA
—
Shares Out
48.6M
Financials (TTM)
Revenue
$96.2M
Net Income
-$12.1M
EBITDA
-$9.4M
Free Cash Flow
$10.6M
Op Cash Flow
$20.1M
EPS Basic
$-0.25
EPS Diluted
$-0.25
EPS Forward
$0.15
Gross Margin
64.6%
Op Margin
-12.6%
Net Margin
-12.6%
Balance Sheet
Total Assets
$405.9M
Total Liab.
$34.0M
Total Equity
$371.9M
Cash
$88.9M
LT Debt
$10.7M
Book Value/Sh
$7.79
Debt/Equity
0.05x
Current Ratio
5.23
Quick Ratio
3.92
Returns & Growth
ROE
-1.2%
ROA
-1.1%
ROIC
-3.1%
Rev Growth YoY
+17.0%
EPS Growth YoY
+43.2%
Price Returns
2W
+18.3%
1M
+18.2%
3M
+3.0%
6M
-6.0%
12M
+13.9%
Technicals
52W High
$28.79
52W Low
$18.15
50d MA
$23.28
200d MA
$23.98
RSI (14)
56.20
ATR (14)
$1.41
Beta
2.00
Avg Volume
734K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$33.00
High
$34.00
Low
$32.00
Median
$33.00
Data updated apr 24, 2026 9:59pm
· Source: financialmodelingprep.com